Skip to main content

Protalix BioTherapeutics, Inc.

PLX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001006281

No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Protalix BioTherapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of PLX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders3833−5
Shares8.82M4.32M−4.51M (−51.1%)
Value$39.4M$8.24M−$31.1M (−79.1%)

New holders (9)

Institutions that held Protalix BioTherapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to PLX in Q2 2021
InstitutionSharesValue% of portfolio
Walleye Capital LLC346,539$662.0K0.02%
Meitav Dash Investments Ltd244,332$467.0K0.01%
Group One Trading, L.P.179,088$342.0K0.01%
Walleye Trading LLC135,000$258.0K0.01%
Susquehanna Fundamental Investments, LLC66,100$126.0K0.00%
XTX Topco Ltd17,148$33.0K0.01%
Cutler Group LP6,900$13.0K0.00%
Red Door Wealth Management, LLC2,000$3.00K0.00%
Deutsche Bank AG873$2.00K0.00%

Sold out (14)

Institutions that held Protalix BioTherapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of PLX in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Burrage Capital Management LLC2,125,585$9.48M
DAFNA Capital Management LLC1,204,825$5.37M
UBS Oconnor LLC445,171$1.99M
D.A. Davidson & Co.130,700$583.0K
Advisor Group Holdings, Inc.122,184$545.0K
Schonfeld Strategic Advisors LLC89,278$399.0K
California Public Employees Retirement System66,631$297.0K
Laurion Capital Management LP42,813$191.0K
Virtu Financial LLC27,744$124.0K
Capstone Investment Advisors, LLC21,058$94.0K
Ground Swell Capital, LLC14,684$65.0K
WealthShield Partners, LLC3,000$13.0K
JPMorgan Chase & Co1,293$6.00K
Aspire Private Capital, LLC400$2.00K